Synthesis and Antiproliferative Activity of Triazoles Based on 2-Azabicycloalkanes
- PMID: 33919613
- PMCID: PMC8072719
- DOI: 10.3390/ma14082039
Synthesis and Antiproliferative Activity of Triazoles Based on 2-Azabicycloalkanes
Abstract
A library of 21 novel chiral 1,2,3-triazole-based 2-azabicycloalkane conjugates was designed and synthesized using the copper(I)-catalyzed click reaction. The obtained hybrids were assessed for their antiproliferative potency against three selected human cancer cell lines: Hs294T (melanoma), MIA PaCa-2 (pancreas tumor) and NCI-H1581 (lung tumor). The majority of the synthesized compounds demonstrated moderate to potent activity, and some of them appeared more selective than cisplatin, with selectivity index exceeding 9.
Keywords: 2-azabicycloalkanes; CuAAC; antiproliferative activity; cancer; triazoles.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organisation Cancer. [(accessed on 10 January 2021)]; Available online: https://www.who.int/news-room/fact-sheets/detail/cancer.
-
- Yet L. Privileged Structures in Drug Discovery: Medicinal Chemistry and Synthesis. Wiley & Sons; Hoboken, NJ, USA: 2018.
-
- Bräse S., editor. Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation. RSC; Cambridge, UK: 2015.
-
- Lauria A., Delisi R., Mingoia F., Terenzi A., Martorana A., Barone G., Almerico A.M. 1,2,3-triazole in heterocyclic compounds, endowed with biological activity, through 1,3-dipolar cycloadditions. Eur. J. Org. Chem. 2014:3289–3306. doi: 10.1002/ejoc.201301695. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
